Fully Integrated With

neoGEN Program Management

##

The neoGen system is a state-of-the-art, technically innovative medical device producing electric cell signaling energy waves (ECST and ESI).

The system successfully treats circulatory issues, acute and chronic pain types, long-term (intractable) pain, and drug-resistant pain. The neoGEN® also offers specific-parameter signaling for efficacious neuromuscular reeducation, muscle strengthening and relaxation of muscle spasm activity.

How neoGEN Works

neoGEN uses a technique called electric cell signaling. It is based on the physics of resonance, which is the electrical signaling between cells. You can think of resonance like a piano being tuned. The tuner strikes the string, adjusting the energy that vibrates along the string. This effect is what creates the sound, so adjusting the string will change the tone.

neoGEN uses an advanced technology called electric cell technology. This is based on the resonance of physics, which is the electrical signaling between the cells. Electric cell signaling treatment (EST) refers to the administration of multiplexed signal energy waves delivered via acomputer-assisted digital (UHdfg) wave generator system. Electric cell signaling treatment (EST) mentions the leading multiplex signal energy waves delivered through the computer-accommodate digital wave transformer system.

Electric Cell Signaling

Reported Clinical Benefits

Applications and Electric Cell Signaling protocols have been subjected to clinical trials. Theresults have been published in numerous academic, scientific and medical publications andliterature. The technologies efficacy is amply demonstrated by these published results and isreinforced anecdotally through the testimonials of thousands of patients.

#

CLINICAL BENEFITS:

Safe, effective, non-invasive, and user-friendly reimbursable treatment

Minimal potential for side effects, easily avoided

Extremely high patient compliance, outcome, and satisfaction

Substantial reduction in out-bound patient referrals

FDA CLINICAL INDICATIONS:

Management and symptomatic relief of chronic (long-term) INTRACTABLE pain

Adjunctive treatment of post-traumatic pain syndromes

Adjunctive treatment in the management of post-surgical pain conditions

Relaxation of muscle spasms

Neuro-muscular reduction

Prevention or retardation of disuse atrophy

Maintaining or increasing range of motion

Increasing local circulation

Immediate post-surgical stimulation of calf muscles to prevent phlebothrombosis

REVENUE GENERATION

Patient treatments utilizing the neoGEN system are reimbursable under various existing CPT codes. The system offers superior patient care, is user-friendly, and creates an additional revenue source for the medical practice. Reimbursements can vary by carrier, specialty, and location; please consult with your local insurance carriers for

information that applies to you and your area. neoGEN will refer your office manager to a national billing institute that specializes in neoGEN technology billing.

#

PUBLISHED

CLINICAL RESEARCH

The neoGEN system has numerous published medical journal reports and studies involving the successful treatment of multiple medical indications, syndromes, and neurogenic pain conditions. The neoGEN system is the original (and only) EST medical system that was clinically utilized with the documented and published Combined Electrochemical Treatment (CET) protocol. Copies of published research are available upon written request.

Terms & ConditionsPrivacy Policy Copyright © 2021 RST. All Rights Reserved.